Birdwatch Note
2023-09-02 18:48:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The FDA has not endorsed or authorized ivermectin for use as a treatment for COVID-19 https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 The FDA has simply given the recommendation that ivermectin not be used. This does not forbid or recommend doctors take any action in prescribing the medication. https://www.factcheck.org/2022/11/fda-did-not-change-position-on-ivermectin-use-contrary-to-online-claims/
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1697986109140304279
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1698045151829012634
- noteId - 1698045151829012634
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1693680487010
- tweetId - 1697986109140304279
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The FDA has not endorsed or authorized ivermectin for use as a treatment for COVID-19 https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 The FDA has simply given the recommendation that ivermectin not be used. This does not forbid or recommend doctors take any action in prescribing the medication. https://www.factcheck.org/2022/11/fda-did-not-change-position-on-ivermectin-use-contrary-to-online-claims/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-09-02 18:48:07 UTC (1693680487010) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-04 02:38:47 UTC (1693795127504) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-09-02 19:30:11 -0500 | Rating Details | |
2023-09-02 19:29:36 -0500 | Rating Details | |
2023-09-02 19:23:48 -0500 | Rating Details | |
2023-09-02 19:23:23 -0500 | Rating Details | |
2023-09-02 19:22:51 -0500 | Rating Details | |
2023-09-02 19:17:06 -0500 | Rating Details | |
2023-09-02 19:06:21 -0500 | Rating Details | |
2023-09-02 19:03:31 -0500 | Rating Details | |
2023-09-02 18:34:26 -0500 | Rating Details | |
2023-09-02 18:24:15 -0500 | Rating Details | |
2023-09-02 18:16:14 -0500 | Rating Details | |
2023-09-02 18:13:42 -0500 | Rating Details | |
2023-09-02 17:36:22 -0500 | Rating Details | |
2023-09-02 17:33:26 -0500 | Rating Details | |
2023-09-02 17:30:20 -0500 | Rating Details | |
2023-09-02 17:22:58 -0500 | Rating Details | |
2023-09-02 17:18:07 -0500 | Rating Details | |
2023-09-02 17:09:48 -0500 | Rating Details | |
2023-09-02 17:04:54 -0500 | Rating Details | |
2023-09-02 17:00:27 -0500 | Rating Details | |
2023-09-02 16:53:31 -0500 | Rating Details | |
2023-09-02 16:43:25 -0500 | Rating Details | |
2023-09-02 16:37:15 -0500 | Rating Details | |
2023-09-02 16:32:47 -0500 | Rating Details | |
2023-09-02 16:31:23 -0500 | Rating Details | |
2023-09-02 16:25:56 -0500 | Rating Details | |
2023-09-02 16:08:08 -0500 | Rating Details | |
2023-09-02 15:58:32 -0500 | Rating Details | |
2023-09-02 15:55:18 -0500 | Rating Details | |
2023-09-02 15:52:51 -0500 | Rating Details | |
2023-09-02 15:50:15 -0500 | Rating Details | |
2023-09-02 15:45:00 -0500 | Rating Details | |
2023-09-02 15:34:28 -0500 | Rating Details | |
2023-09-02 15:32:40 -0500 | Rating Details | |
2023-09-02 15:31:29 -0500 | Rating Details | |
2023-09-02 15:30:57 -0500 | Rating Details | |
2023-09-02 15:30:23 -0500 | Rating Details | |
2023-09-02 15:29:50 -0500 | Rating Details | |
2023-09-02 15:23:29 -0500 | Rating Details | |
2023-09-02 15:15:49 -0500 | Rating Details | |
2023-09-02 15:13:40 -0500 | Rating Details | |
2023-09-02 15:03:18 -0500 | Rating Details | |
2023-09-02 15:03:06 -0500 | Rating Details | |
2023-09-02 14:55:15 -0500 | Rating Details | |
2023-09-02 14:50:15 -0500 | Rating Details | |
2023-09-02 14:48:39 -0500 | Rating Details | |
2023-09-02 14:46:38 -0500 | Rating Details | |
2023-09-02 14:39:36 -0500 | Rating Details | |
2023-09-02 14:38:25 -0500 | Rating Details | |
2023-09-02 14:37:40 -0500 | Rating Details | |
2023-09-02 14:27:33 -0500 | Rating Details | |
2023-09-02 14:25:08 -0500 | Rating Details | |
2023-09-02 14:24:37 -0500 | Rating Details | |
2023-09-02 14:23:41 -0500 | Rating Details | |
2023-09-02 14:22:56 -0500 | Rating Details | |
2023-09-02 14:21:55 -0500 | Rating Details | |
2023-09-02 14:18:56 -0500 | Rating Details | |
2023-09-02 14:17:13 -0500 | Rating Details | |
2023-09-02 14:12:58 -0500 | Rating Details | |
2023-09-02 14:04:57 -0500 | Rating Details | |
2023-09-02 14:03:22 -0500 | Rating Details | |
2023-09-02 13:59:05 -0500 | Rating Details | |
2023-09-02 13:58:16 -0500 | Rating Details | |
2023-09-02 13:53:50 -0500 | Rating Details | |
2023-09-02 13:53:07 -0500 | Rating Details | |
2023-09-02 13:52:15 -0500 | Rating Details | |
2023-09-03 19:05:08 -0500 | Rating Details | |
2023-09-03 17:55:23 -0500 | Rating Details | |
2023-09-03 17:10:41 -0500 | Rating Details | |
2023-09-03 16:34:19 -0500 | Rating Details | |
2023-09-03 16:25:18 -0500 | Rating Details | |
2023-09-03 15:06:25 -0500 | Rating Details | |
2023-09-03 14:40:54 -0500 | Rating Details | |
2023-09-03 12:48:50 -0500 | Rating Details | |
2023-09-03 12:39:00 -0500 | Rating Details | |
2023-09-03 12:11:52 -0500 | Rating Details | |
2023-09-03 11:11:53 -0500 | Rating Details | |
2023-09-03 10:54:24 -0500 | Rating Details | |
2023-09-03 10:45:08 -0500 | Rating Details | |
2023-09-03 10:19:32 -0500 | Rating Details | |
2023-09-03 10:07:06 -0500 | Rating Details | |
2023-09-03 09:58:00 -0500 | Rating Details | |
2023-09-03 09:52:52 -0500 | Rating Details | |
2023-09-03 09:52:42 -0500 | Rating Details | |
2023-09-03 09:44:33 -0500 | Rating Details | |
2023-09-03 09:21:46 -0500 | Rating Details | |
2023-09-03 09:19:06 -0500 | Rating Details | |
2023-09-03 09:14:08 -0500 | Rating Details | |
2023-09-03 08:57:04 -0500 | Rating Details | |
2023-09-03 08:45:56 -0500 | Rating Details | |
2023-09-03 08:29:34 -0500 | Rating Details | |
2023-09-03 08:21:42 -0500 | Rating Details | |
2023-09-03 08:19:21 -0500 | Rating Details | |
2023-09-03 08:16:43 -0500 | Rating Details | |
2023-09-03 08:16:36 -0500 | Rating Details | |
2023-09-03 07:52:02 -0500 | Rating Details | |
2023-09-03 07:38:34 -0500 | Rating Details | |
2023-09-03 07:31:16 -0500 | Rating Details | |
2023-09-03 07:31:01 -0500 | Rating Details | |
2023-09-03 07:04:53 -0500 | Rating Details | |
2023-09-03 06:57:38 -0500 | Rating Details | |
2023-09-03 06:55:32 -0500 | Rating Details | |
2023-09-03 06:45:58 -0500 | Rating Details | |
2023-09-03 06:40:14 -0500 | Rating Details | |
2023-09-03 06:39:09 -0500 | Rating Details | |
2023-09-03 06:38:20 -0500 | Rating Details | |
2023-09-03 06:20:46 -0500 | Rating Details | |
2023-09-03 06:17:37 -0500 | Rating Details | |
2023-09-03 06:16:23 -0500 | Rating Details | |
2023-09-03 06:14:34 -0500 | Rating Details | |
2023-09-03 05:54:55 -0500 | Rating Details | |
2023-09-03 05:12:58 -0500 | Rating Details | |
2023-09-03 05:00:49 -0500 | Rating Details | |
2023-09-03 05:00:41 -0500 | Rating Details | |
2023-09-03 04:58:14 -0500 | Rating Details | |
2023-09-03 04:48:31 -0500 | Rating Details | |
2023-09-03 04:29:17 -0500 | Rating Details | |
2023-09-03 04:25:55 -0500 | Rating Details | |
2023-09-03 04:21:31 -0500 | Rating Details | |
2023-09-03 04:17:04 -0500 | Rating Details | |
2023-09-03 03:58:58 -0500 | Rating Details | |
2023-09-03 03:31:13 -0500 | Rating Details | |
2023-09-03 03:22:24 -0500 | Rating Details | |
2023-09-03 02:47:25 -0500 | Rating Details | |
2023-09-03 02:43:04 -0500 | Rating Details | |
2023-09-03 02:18:42 -0500 | Rating Details | |
2023-09-03 01:41:10 -0500 | Rating Details | |
2023-09-03 01:38:28 -0500 | Rating Details | |
2023-09-03 01:31:22 -0500 | Rating Details | |
2023-09-03 01:14:40 -0500 | Rating Details | |
2023-09-03 01:09:57 -0500 | Rating Details | |
2023-09-03 01:08:31 -0500 | Rating Details | |
2023-09-03 01:03:02 -0500 | Rating Details | |
2023-09-03 00:34:19 -0500 | Rating Details | |
2023-09-03 00:28:23 -0500 | Rating Details | |
2023-09-03 00:07:02 -0500 | Rating Details | |
2023-09-03 00:06:39 -0500 | Rating Details | |
2023-09-02 23:37:24 -0500 | Rating Details | |
2023-09-02 23:27:15 -0500 | Rating Details | |
2023-09-02 23:11:13 -0500 | Rating Details | |
2023-09-02 22:57:23 -0500 | Rating Details | |
2023-09-02 22:35:00 -0500 | Rating Details | |
2023-09-02 22:25:01 -0500 | Rating Details | |
2023-09-02 22:04:34 -0500 | Rating Details | |
2023-09-02 22:01:50 -0500 | Rating Details | |
2023-09-02 22:01:09 -0500 | Rating Details | |
2023-09-02 21:53:16 -0500 | Rating Details | |
2023-09-02 21:52:06 -0500 | Rating Details | |
2023-09-02 21:41:23 -0500 | Rating Details | |
2023-09-02 21:38:06 -0500 | Rating Details | |
2023-09-02 21:32:42 -0500 | Rating Details | |
2023-09-02 21:27:37 -0500 | Rating Details | |
2023-09-02 21:25:05 -0500 | Rating Details | |
2023-09-02 21:18:53 -0500 | Rating Details | |
2023-09-02 21:17:35 -0500 | Rating Details | |
2023-09-02 21:10:47 -0500 | Rating Details | |
2023-09-02 21:05:01 -0500 | Rating Details | |
2023-09-02 20:59:51 -0500 | Rating Details | |
2023-09-02 20:58:21 -0500 | Rating Details | |
2023-09-02 20:42:55 -0500 | Rating Details | |
2023-09-02 20:37:31 -0500 | Rating Details | |
2023-09-02 20:34:39 -0500 | Rating Details | |
2023-09-02 20:33:55 -0500 | Rating Details | |
2023-09-02 20:33:54 -0500 | Rating Details | |
2023-09-02 20:33:46 -0500 | Rating Details | |
2023-09-02 20:32:57 -0500 | Rating Details | |
2023-09-02 20:32:36 -0500 | Rating Details | |
2023-09-02 20:29:07 -0500 | Rating Details | |
2023-09-02 20:21:30 -0500 | Rating Details | |
2023-09-02 20:18:42 -0500 | Rating Details | |
2023-09-02 20:15:22 -0500 | Rating Details | |
2023-09-02 20:11:06 -0500 | Rating Details | |
2023-09-02 20:10:57 -0500 | Rating Details | |
2023-09-02 20:10:39 -0500 | Rating Details | |
2023-09-02 20:09:54 -0500 | Rating Details | |
2023-09-02 20:09:40 -0500 | Rating Details | |
2023-09-02 20:09:01 -0500 | Rating Details | |
2023-09-02 20:06:36 -0500 | Rating Details | |
2023-09-02 20:05:29 -0500 | Rating Details | |
2023-09-02 19:57:11 -0500 | Rating Details | |
2023-09-02 19:53:36 -0500 | Rating Details | |
2023-09-02 19:52:13 -0500 | Rating Details | |
2023-09-02 19:51:52 -0500 | Rating Details | |
2023-09-02 19:48:58 -0500 | Rating Details | |
2023-09-02 19:34:17 -0500 | Rating Details | |
2023-09-04 00:38:30 -0500 | Rating Details | |
2023-09-03 23:30:46 -0500 | Rating Details | |
2023-09-03 23:11:43 -0500 | Rating Details | |
2023-09-03 21:55:14 -0500 | Rating Details | |
2023-09-03 21:21:36 -0500 | Rating Details | |
2023-09-03 19:51:23 -0500 | Rating Details | |
2023-09-03 19:41:31 -0500 | Rating Details | |
2023-09-06 07:28:26 -0500 | Rating Details | |
2023-09-09 08:26:31 -0500 | Rating Details | |
2023-09-08 23:19:00 -0500 | Rating Details | |
2023-12-31 11:17:03 -0600 | Rating Details | |
2024-01-15 06:49:03 -0600 | Rating Details | |
2024-01-15 01:09:45 -0600 | Rating Details | |
2024-01-15 00:49:24 -0600 | Rating Details | |
2024-01-14 20:59:45 -0600 | Rating Details | |
2024-01-14 20:54:02 -0600 | Rating Details | |
2024-01-14 19:55:06 -0600 | Rating Details | |
2024-01-14 18:27:31 -0600 | Rating Details | |
2024-01-14 18:19:55 -0600 | Rating Details | |
2024-01-14 18:01:16 -0600 | Rating Details | |
2024-01-14 16:52:44 -0600 | Rating Details | |
2024-01-14 15:54:36 -0600 | Rating Details | |
2024-01-14 15:33:28 -0600 | Rating Details | |
2024-01-14 15:22:47 -0600 | Rating Details | |
2024-01-14 15:14:30 -0600 | Rating Details | |
2024-01-14 14:23:25 -0600 | Rating Details | |
2024-01-14 14:18:58 -0600 | Rating Details | |
2024-01-15 02:42:18 -0600 | Rating Details | |
2024-01-14 22:09:24 -0600 | Rating Details | |
2024-01-14 21:34:33 -0600 | Rating Details | |
2024-01-14 21:21:08 -0600 | Rating Details | |
2024-01-14 21:15:08 -0600 | Rating Details | |
2024-01-14 21:08:11 -0600 | Rating Details | |
2024-01-14 19:11:09 -0600 | Rating Details | |
2024-01-14 19:10:52 -0600 | Rating Details | |
2024-01-14 18:02:04 -0600 | Rating Details | |
2024-01-14 18:00:03 -0600 | Rating Details | |
2024-01-14 17:54:40 -0600 | Rating Details | |
2024-01-14 17:41:27 -0600 | Rating Details | |
2024-01-14 16:29:14 -0600 | Rating Details | |
2024-01-14 15:27:01 -0600 | Rating Details | |
2024-01-14 15:22:21 -0600 | Rating Details | |
2024-01-14 15:20:39 -0600 | Rating Details | |
2024-01-14 14:55:03 -0600 | Rating Details | |
2024-01-14 14:47:48 -0600 | Rating Details | |
2024-01-14 14:25:15 -0600 | Rating Details | |
2024-01-14 14:23:26 -0600 | Rating Details | |
2024-01-14 14:15:29 -0600 | Rating Details | |
2024-01-14 14:06:15 -0600 | Rating Details | |
2024-01-23 11:16:23 -0600 | Rating Details | |
2024-02-13 11:31:02 -0600 | Rating Details |